CRBC News
Politics

Supreme Court Temporarily Restores Broad Access to Mifepristone via Mail, Pharmacies and Telehealth

Supreme Court Temporarily Restores Broad Access to Mifepristone via Mail, Pharmacies and Telehealth
FILE - Mifepristone tablets sit on a table at a Planned Parenthood clinic in Ames, Iowa, July 18, 2024. (AP Photo/Charlie Neibergall, File)(ASSOCIATED PRESS)

The Supreme Court on Monday temporarily restored broad access to the abortion pill mifepristone, blocking a recent federal appeals-court restriction. Justice Samuel Alito signed an emergency order allowing pharmacy dispensing, mail delivery and telehealth prescriptions without an in-person visit while the court reviews the case. The decision responds to a lawsuit by Louisiana and emergency appeals from mifepristone manufacturers, and the order will remain in place for one week as both sides file responses.

In Washington on Monday, the U.S. Supreme Court temporarily restored broad access to the abortion drug mifepristone, blocking a lower-court ruling that would have restricted one of the primary ways people obtain abortions nationwide.

Supreme Court Temporarily Restores Broad Access to Mifepristone via Mail, Pharmacies and Telehealth
The Supreme Court is seen, Thursday, April 30, 2026, in Washington. (AP Photo/Jacquelyn Martin)(ASSOCIATED PRESS)

What the Order Does

The short-term order, signed by Justice Samuel Alito, allows patients to obtain mifepristone at pharmacies or through the mail and to receive prescriptions via telehealth without an in-person doctor visit while the court considers the case. The emergency action reverses new restrictions imposed last week by a federal appeals court.

Supreme Court Temporarily Restores Broad Access to Mifepristone via Mail, Pharmacies and Telehealth
The U.S. Supreme Court is seen, Thursday, April 30, 2026, in Washington. (AP Photo/Mariam Zuhaib)(ASSOCIATED PRESS)

Why It Matters

Most abortions in the United States are now provided with medication, typically a two-drug regimen of mifepristone followed by misoprostol. Wider access to these medications has softened the impact of state abortion bans enacted after the Supreme Court's 2022 decision overturning Roe v. Wade.

Legal Fight

The challenge that prompted the appeals-court restrictions was brought by Louisiana, which argued that broader availability of mifepristone undermines the state’s abortion ban. Manufacturers of mifepristone filed emergency appeals asking the Supreme Court to step in.

Next Steps

Alito's order remains in effect for one week while both sides file responses and the full court more fully considers the legal issues. The Supreme Court’s temporary action preserves current access for now but does not represent a final ruling on the merits of the case.

Note: This is a temporary, emergency order. Parties on both sides will have an opportunity to respond before the court issues any longer-term decision.

Help us improve.

Related Articles

Trending